ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Overview Fund Activity
Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

44 hedge funds and large institutions have $2.75M invested in Zynerba Pharmaceuticals, Inc in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 10 closing their positions.

Holders
44
Holders Change
-6
Holders Change %
-12%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
13
Closed
10
Calls
$10K
Puts
–
Net Calls
+$10K
Net Calls Change
-$22K

Top Buyers

1
Wells Fargo
1
Wells Fargo
California
$63.1K
2
VF
2
Virtu Financial
New York
$14K
3
HF
3
HRT Financial
New York
$8K
4
RJFSA
4
Raymond James Financial Services Advisors
Florida
$6.11K
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$5K

Top Sellers

1
EMG
1
ETF Managers Group
New Jersey
$311K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$245K
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$0
4
IEFM
4
IQ EQ Fund Management
Ireland
$0
5
Millennium Management
5
Millennium Management
New York
$196K
Name Market Value Shares Shares
Change 		Shares
Change %
Citigroup
51
Citigroup
New York
– – -100 Closed
Northwestern Mutual Wealth Management
52
Northwestern Mutual Wealth Management
Wisconsin
– – -3 Closed
Susquehanna International Group
53
Susquehanna International Group
Pennsylvania
– – – –
LC
54
Lindbrook Capital
California
$0 1 – –
IHWM
55
Iron Horse Wealth Management
Iowa
$0 1 – –
1 2
3